Glutanex Injection or Gluta-1? The Differences and a Pre-Order Checklist

1. A side-by-side comparison based on the official source

The information below is taken from the official pages of both products and was reviewed on August 21, 2026. Wherever the source gives no information, we say so, so that the gap is not filled with guesswork.

• Name and identity: Glutanex Injection versus Gluta-1; two products with separate identities.
• Active ingredient and amount: both contain glutathione, and the official source states 1200 mg per vial for both; however, the strength as produced is not always fixed, and for Glutanex Injection some batches are supplied as 600 mg vials. The amount printed on the specific batch must be confirmed before ordering.
• Form: both freeze-dried (lyophilised).
• Count: both have 10 vials per pack.
• Packaging: Gluta-1 is identified by its pink box; Glutanex Injection has the Glutanex family packaging.
• Stated route: Gluta-1: intravenous (IV) or intramuscular (IM) as per the pack. Glutanex Injection: route information is not consistent across sections of the source; only the registered leaflet is the reference.
• Excipients: not recorded for either in the current data; they must be checked in the leaflet for that specific batch.
• Storage: both in the closed container, away from light, at 1 to 30 °C according to the source.

2. Why they are not "the same product"

In professional supply, a product's identity is defined by its registration and registered leaflet, not by its active ingredient. Two products with the same ingredient and amount can differ in excipients, manufacturing process, registered route, target market and documentation. When the official source prints an IV or IM route on the Gluta-1 pack but gives no consistent information for Glutanex Injection, it is precisely this difference in documentation that makes automatic substitution invalid.

That is why LILWANA stresses on each product page that Gluta-1 should not be substituted for Glutanex Injection without matching the name and the leaflet. This is not an administrative precaution; it is a tool for preventing errors in records, invoices and clinical decisions.

3. A reminder about the evidence for injectable glutathione

Comparing the two products should not obscure the main question of what support injectable glutathione has for cosmetic purposes. The review by Sonthalia et al. states that, despite its popularity, there is no evidence proving the efficacy of intravenous glutathione in lightening the skin, and that reported adverse effects led to a public warning from the Philippine Food and Drug Administration. The 2025 review also lists liver injury and anaphylactic reactions among the risks of the intravenous form.

Choosing either of these products is therefore a medical decision based on the registered use and the individual's condition. LILWANA promises no cosmetic result, success rate or timeframe for either, and does not consider a higher amount to mean a better result.

4. Verification checklist before ordering

• The exact product name in the inquiry: Glutanex Injection or Gluta-1, not the vague phrase "Glutanex 1200".
• The amount printed on the vial for that specific batch (for example 1200 or 600 mg) should be stated before the order is confirmed and matched against the invoice and label on delivery.
• The name on the box and vial should match the physician's approved prescription or plan.
• The batch number and the manufacturing and expiry dates on the box and vial should be identical.
• The leaflet for that specific batch should be inside the pack, and the permitted route and excipients should be read from that leaflet.
• For Gluta-1, the pink box and the route printed on the pack should match what the centre expects.
• Storage conditions of 1 to 30 °C and protection from light should be provided at the centre, and the temperature recorded.
• The exact product name and batch number should be recorded in the patient's file to avoid ambiguity in later follow-up.

5. The inquiry route at LILWANA

Both products are reviewed only through the professional inquiry form and only for qualified centres. In the inquiry, enter the exact product name, number of packs and the centre's details. LILWANA checks the product's identity, batch, dates, integrity of the pack and supply conditions, and provides the leaflet for that specific batch with its response. Choosing between these two products, the amount and the method of administration fall outside the scope of LILWANA's response and rest solely with the physician.